This inventor holds 1 USPTO granted patent. Top assignee: Regenxbio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Jean Bennett in Age-Related Macular Degeneration Treatment.
Introduction
Jean Bennett is a notable inventor based in Bryn Mawr, PA (US). He has made significant contributions to the field of medical treatments, particularly focusing on age-related macular degeneration. His work has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Jean Bennett holds a patent for "Compositions for Treatment of Wet Age-Related Macular Degeneration." This patent represents a crucial advancement in the therapeutic options available for patients dealing with this debilitating eye condition. He has 1 patent to his name, showcasing his innovative approach to medical science.
Career Highlights
Bennett is associated with Regenxbio Inc., a company that specializes in gene therapy and innovative treatments. His role at the company allows him to collaborate with other experts in the field, further enhancing the impact of his work.
Collaborations
Some of his notable coworkers include Anna Tretiakova and Sherri Van Everen. Their combined expertise contributes to the development of groundbreaking treatments in the medical field.
Conclusion
Jean Bennett's contributions to the treatment of age-related macular degeneration highlight his innovative spirit and dedication to improving patient outcomes. His work at Regenxbio Inc. and his patent for new treatment compositions are significant milestones in the ongoing fight against this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile